A | B (persisters) | C | D | |
Site of bacilli | Extra-cellular in cavity | Intra-cellular in MQs | Extra-cellular in caseum | Dormant fatty |
Responds to | S, H, R | Z, H, R | R only | Nothing |
Resistant to | Z | S | H, Z, S, E | All |
PH needed | Neutral or Alk. | Acidic | Neutral | _ |
O2 tension | Needs high | _ | Needs low | _ |
Responsible for | Ttt failure | Relapse (must >2Ms ttt) | _ | _ |
· Drugs used in TB:
a) 1st Line Drugs:
INH | R | P.T.B | E.T.B | S | ||
Dose (adult-child) | 5-10mg/kg/d (max 300-600mg) | 10-20mg/kg (max 600mg for >50kg, 450mg for <50kg) | 25-40mg/kg (max 2gm for >50kg, 1.5gm for <50kg) | 15-25mg/kg (0.8-1.2gm) | 15mg/kg/d (max 1gm) | |
Prep. | .Isocid 100 .I.forte 200 .Inhibex (50H+5Z) .TBzide 50 .Rimactazide .Riozid (300R+150H) | .Rifadin (v:600)(c:150/300) .Rimactan (cap/syrup) .Rifampin300 .Rifampicin | .P.T.B 500 .Pyrazide 500 .Pyraldina 500 .Rifater 2 (H,R,Z = 50,120,300) | .E.T.B 500, 100, 400 | .Strept IM (ineffective more than 2Ms and toxic as well) | |
Mech. Of Action | -Bactericidal -IC/EC -Inh. synth. of DNA, cell wall Mycolic acid. -Acts on replicating bacilli (even in persisters they are slowly replicating not completely dormant. -Competes pyridoxine (structure analogue). -On empty stomach as R. | -Bactericidal -IC/EC (kills intermittently, rapidly dividing org.) -Dec.RNA synthesis through Dec. DNA depend. RNA polymerase. -Also on: G+ve/-ve, pox virus, Chlamydia, Mycoplasma. | -Bactericidal -IC only (acidic media) -Change by pyrazinamidase of bacillus to pyrazinoic acid (wall). -Must do pre-ttt sensitivity test. -Main ttt in relapse and short course ttt (sterilizing) -No effect in continuation phase. | -Bacteriostatic -IC/EC -Dec. RNA synthesis to inhibit MB cell wall synthesis. | -Bactericidal -EC only (alk. media) -Binds to 30S ribosomal subunità prevents protein synthesis. -Break polysomes to monosomes. -Misreading in genetic code à abn. Protein. -Inactivates initial complex of synthesis. | |
Absorpt. Peak conc Metabol. Half life Excretion Penetrat. | -Easy -2 hrs -Acetylators (rapid/slow) -1.5-3 hrs -Urine - Crosses BBB | -In ½ hr -3 hrs -75% bound, partial deacetylation in liveràbile -5 hrs -Bile, less Urine (EHC). -Inflamed meninges. only, well to other tissues. | ----------------- -1-2 hrs -50% bound, hepatic deaminase changes it to active pyridazinoic acid then with xanthine oxidase to inactive metabolite. ------------------Urine -CSF=plasma conc. -Dose decreased in renal failure. | -Inh. 'e ethanol , alumOH -2-4 hrs -Not altered with liver disease. -must suspend at once. -------------------Urine unchanged. -No cross BBB even inflamed. -Dose decreased in renal failure (drug level not>5ug/ml) (not used in clearance <50) | ---------------- -1 hr -Cross-resistance with vio/ kanamycin -----------------Urine completely. -Inflamed meninges. -Crosses placenta (1/2 mother's level). | |
S.Es.CNS .Eye .Ear .Allergy .BM dep. .Blood .GIT .Liver .Pancreas .Kidney .Adrenal .Bone .Resistanc .Drug interact. .Others Follow up | -PN (slow A), insomnia, restlessness, Ms twitches, Convulsions in epileptic pt. -Atropine like (dry mouth, tinnitus, GIT) -Rash, Fever, Pellagra (nicotinamide) -Inhibit Histaminases (inc. histamin) +ve -Hemolytic anemia -GIT upset -Hepatitis (rapid A) -D.M.(x B-cells) -Lupus like ----------------- ----------------- +ve -Hydralazine, Procainamide, PAS inc. its toxicity. -Carcinogenic in mice -/4wks CBC, liver function, -/3Ms urine test for compliance. -Caution in epilepsy, alcoholics, pregnant | ----------------Conjunctivitis - -Flu symp., asthma, purpra, ATN ('eintermittent ttt) -----------------A.hemolytic anemia, thrombocytopenic purpra. -Pseudo-memb.colitis. -Transient insig. inc. transaminases, Cholestatic jaundice. -----------------Light chain protinuriaàRF, ATN -Pseud crisis -Osteomalacia +ve -PAS inh. Its absorption. -R is enzyme inducer. -Turns fluids red. -Teratogenic -as INH -as INH -caution in pregnancy | -----------------Photosensitivity (Erythema with sunlt.) -as eye ------------------Sideroblastic anemia. -GIT upset -Hepatitis (most hepatotoxic drug) ---------------------------------- ----------------- -Arthralgia, Gout (comp.'e uric A. excretion àPAS dec. it +ve -PAS decreases hyperuricemia ----------------- -as INH -as INH -uric acid | -PN, -Retro-bulbar neuritis (optic atrophy rev. dose depend., central>periph) (given to >13yr pt only to detect abnormality) -as others ------------------Thrombocytopenia. -GIT upset -Jaundice ------------------------------------ ------------------ - Hyperuricemia +ve ------------------ ------------------ -examine each eye separately /4wks with CBC and urine and uric acid. -caution in children, renal patients. | -----------------Vestibulo-cochlear damage (rev.) (V1st then C) -fetal Ototox. -as others -----------------Blood discariasis (an., tcp, agranulocyt.) -low Ca, Mg, K -GIT upset ---------------- -----------------Renal tubular damage (irrev.) ------- ---------------- +ve, cross R -Curare like action (when used with D-tubocurarine topically) -Teratogenic -/4wks renal function -as INH -caution in renal, prev. hearing problem,preg. |
b) 2nd Line Drugs: (reserve drugs)
Thioacetazone (not in WHO) | PAS acid | Cycloserine | Ethionamide/ pro-ethiona. | Fluorinated Quinolones | |
Dose | 2-4 mg/kg (150mg/d) | 150-300 mg/kg | 15 mg/kg (1gm max) | 15 mg/kg (max 0.75-1) | 800mg (tarivid 600) |
Prep. | +H = 150-300 + 50-100mg | 500mg tab., IV in mening. | 500mg tab. | .Trecator 250 .Isoprodian (proeth.+ H + Dapsone) | .Moxifloxacin (best, safe, tolerable) .Ofloxacin .Ciprofloxacin .Norfloxacin .Sparfloxacin (less eff.on atypical MB) |
Action | -Bacteriostatic -IC/EC -Thiosemi carbazone gp. -Used 1st line instead S or E -Tolerated by africans. | Bacteriostatic -IC/EC caseum -Delay Resist -Like sulphonamides -Competes with PABA for di-hydro-petroate synthetase in folic acid synth. Pathway. | Bacteriostatic -Effect. in non human TB -Competes with D-alanine 4 synth. of cell wall peptidoglycans | -Bactericidal -Effect. In bovine type -Structural similarity to INH and same way of action. | -Bactericidal -Used with MDR -Inhibits DNA gyrase. |
Kinetics | --- | .Good absorb. .Acetylation .Inactive in urine. .Cross BBB if inflamed. .No adjust. in RF /LCF. | -No cross R -Cross BBB -Excreted in kidney. | -Acetylation -Eth. à Eth. Sulphoxide (potent) -Excreted in urine. (Pro-eth. is less toxic) | -Excreted unchanged in urine. -Safe in LCF. -Adjusted in RF. |
S.Es | -Cerebral edema. -Ototoxicity ofS -GIT upset -Liver toxicity -D.M. -Bl. discariasis -Exfoliative dermatitis with HIV -Chinese rash with cheese meals, fish. -Cross R with Ethionamide/pro | -Goitrogenic -Glandulat like fever -GIT upset,PU -Liver damage -Dec. glucose -Bl. discariasis -Allergy (rash/fever) -dec.K, inc.Ca -Crystalluria in kid.(not 'e S) (phenstix strips in urine) -Drug interactions: .R/H/Z (CB4) .Probencid (inc. toxicity) .'e Aspirin (salicylism). | -Psychosis, dep, tremors, convulsions, slurred speech, confusion (add B6 50mg) -GIT upset -D.M. -Adjust in renal failure | -Psychosis, PN -Dec. T4 -GIT upset (metallic taste, sulpher eructation). -Dec. glucose. -Allergy -Liver damage -Teratogenic -Gynecomastia, impotence, menstrual irregularities, acne. -Cross R with thioacetazone | -Headache, insomnia, tremors. -GIT upset. -Liver enzymes high -Leucopenia -Damage articular cartilage (<16yrs) -Drug interactions: (except oflo.) .NSAIDs .Cimetidine. .Cyclosporine. .Theophylline. .Warfarin. |
FU | Caution for S.Es and urine test/ 3Ms for compliance |
Slow:à 1/10 dose à double every 12hrs à full dose.
c) New Drugs: (not in WHO except aminoglycosides)
- Clofazimine (Iminopherazine derivative):
.Action: anti-leprosy & antiTB in vitro
.Peak conc.: in 1M
.S.Es: à Crystalline deposits in organs (sp. In fat content)
à Brownish-black pigmentation of skin
à Severe life threatening abdominal pain
- B-lactam/ B-anti-lactamase: in vitro > in vivo so it has a limited use as it
poorly penetrates mammalian cells.
- Macrolides: Concentrated in MQs à antiTB effect (IC) so prevents
multiplication. (Azithro., Roxithro., Clarithromycins)
- Rifamycins: in vitro
Rifapentin | Rifalazil | Rifabutin | |
Derived from | Cyclopentyl | ---- | Spiropiperidyl |
Activity on TB | >20 times than R | Intermediate between both | Used in R resistance Used in M. avian complex > R |
Half life | 20 hrs | Longest | 16 hrs, rapid abs. |
Dose | 600mg once/wk | ---- | 5mg/kg/d 150mg/d in new case 300mg/d in MDR 600mg/d in avian |
Resistance | Cross with R | ---- | Used in R resistance |
- O xazolidinones (Linezolid):
.Used in: MDR and drug resistant G +ve coccal infections.
.S.Es: hematological, PN, expensive.
- Nitroimidazopyranes (Metronidazole derivative):
Bactericidal against Dormant TB & bacilli in anaerobic environment.
- Aminoglycosides:
.Action: Bactericidal
.Preparations: Amikin, Capreomycin, Kanamycin, Viomycin
.Dose: 15mg/kg/d or max. 0.75-1gm (all IM only except amikin can
be given IV too)
.S.Es: 1st 2 drugs à auditory = vestibular effects
2nd 2 drugs à auditory > vestibular effects
- Others: à Analogues of Z (but more active, no cross resistance)
à Drugs target iso-citrate lyase (enzyme that establishes latent TB)
à Immuno-modulation (improve effect of ttt):
.M. Vaccae (for protective cytokine release)
.Post-infection vaccine with LIBI
.Protective cytokines (INFg, IL12, GMCSF)
.Levamisole
.Transfer factors
à Alternative drug delivery system:
.Implanted SC slow release Z, H
.Inhalation micro particles (dec. dose/toxicity)
(stimulates alveolar MQs)
.Liposomal encapsulation of antiTB (on MQs)
d) Steroids in TB:
à Collagen disorders
à Sarcoidosis
à Transplanted organ
à TB meningitis, pericarditis, peritonitis
(decrease adhesions)
à TB urethritis (dec. stricture)
à TB salpingitis and in vas
à Suppress LN enlargement during
chemotherapy when symptomatizing
.Response: gives rapid improvement to fever, weight loss, ESR level,
exaudative lesion.
.Dose: 20mg/d (60 in pericarditis) à 4-6wks orally
then taper 5mg/d every wk (given under cover of anti-TB)
*N.B.
Thalidomide is used instead of steroids in TB meningitis when no response.
*For Full Text --> download from:
Tuberculosis.pdf
No comments:
Post a Comment